Veracyte

Veracyte VCYT Stock

$47.93   4.105125%
Add to favorites
Market Cap
$3.85B
LOW - HIGH [24H]
$45.48 - $48.06
VOLUME [24H]
$906.01K
P/E Ratio
34.23
Earnings per share
$1.40
ISIN
US92337F1075
Price   Prediction

Veracyte Price Chart

Sorry, that's all we've gotfor now...

Veracyte VCYT Financial and Trading Overview

Veracyte stock price 47.93 USD
Previous Close 46.04 USD
Open 45.87 USD
Bid 33.3 USD x 200
Ask 59.52 USD x 200
Day's Range 45.48 - 48.06 USD
52 Week Range 29.46 - 60.91 USD
Volume 905.99K USD
Avg. Volume 1.37M USD
Market Cap 3.85B USD
Beta (5Y Monthly) 1.947
PE Ratio (TTM) 32.828766
EPS (TTM) 1.4 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 59.73 USD

VCYT Valuation Measures

Enterprise Value 3.41B USD
Trailing P/E 32.828766
Forward P/E 24.665373
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 6.857319
Price/Book (mrq) 2.7743692
Enterprise Value/Revenue 6.065
Enterprise Value/EBITDA 30.022

Trading Information

Veracyte Stock Price History

Beta (5Y Monthly) 1.947
52-Week Change 33.24%
S&P500 52-Week Change 10.88%
52 Week High 60.91 USD
52 Week Low 29.46 USD
50-Day Moving Average 43.56 USD
200-Day Moving Average 42.64 USD

VCYT Share Statistics

Avg. Volume (3 month) 1.37M USD
Avg. Daily Volume (10-Days) 1.09M USD
Shares Outstanding 80.39M
Float 79.89M
Short Ratio 7.05
% Held by Insiders 0.54%
% Held by Institutions 114.89%
Shares Short 10.18M
Short % of Float 14.96%
Short % of Shares Outstanding 12.65%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 20.37%
Operating Margin (ttm) 15.28%
Gross Margin 73.75%
EBITDA Margin 20.20%

Management Effectiveness

Return on Assets (ttm) 4.09%
Return on Equity (ttm) 8.77%

Income Statement

Revenue (ttm) 561.9M USD
Revenue Per Share (ttm) 7.08 USD
Quarterly Revenue Growth (yoy) 15.50%
Gross Profit (ttm) 414.44M USD
EBITDA 113.52M USD
Net Income Avi to Common (ttm) 114.48M USD
Diluted EPS (ttm) 1.46
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 485.23M USD
Total Cash Per Share (mrq) 6.04 USD
Total Debt (mrq) 40.11M USD
Total Debt/Equity (mrq) 2.89 USD
Current Ratio (mrq) 9.162
Book Value Per Share (mrq) 17.276

Cash Flow Statement

Operating Cash Flow (ttm) 178.38M USD
Levered Free Cash Flow (ttm) 106.23M USD

Profile of Veracyte

Country United States
State CA
City South San Francisco
Address 6000 Shoreline Court
ZIP 94080
Phone 650 243 6300
Website https://www.veracyte.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 755

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Q&A For Veracyte Stock

What is a current VCYT stock price?

Veracyte VCYT stock price today per share is 47.93 USD.

How to purchase Veracyte stock?

You can buy VCYT shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Veracyte?

The stock symbol or ticker of Veracyte is VCYT.

Which industry does the Veracyte company belong to?

The Veracyte industry is Diagnostics & Research.

How many shares does Veracyte have in circulation?

The max supply of Veracyte shares is 80.39M.

What is Veracyte Price to Earnings Ratio (PE Ratio)?

Veracyte PE Ratio is 34.23571400 now.

What was Veracyte earnings per share over the trailing 12 months (TTM)?

Veracyte EPS is 1.4 USD over the trailing 12 months.

Which sector does the Veracyte company belong to?

The Veracyte sector is Healthcare.

Veracyte VCYT included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 25955.34 USD —
-0.21
5.73B USD — 25866.15 USD — 26111.62 USD — — 5.73B USD —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech US 700 Small Cap Value N NQUS700SCVN US 3083.18 USD —
-0.45
— — 3054.98 USD — 3085.16 USD — — — —
us US Tech US 700 Small Cap Index NQUS700SC US 3009.36 USD —
-0.47
— — 2982.52 USD — 3012.47 USD — — — —
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 3770.94 USD —
-0.28
— — 3736.98 USD — 3784.46 USD — — — —
us US Tech Biotechnology NBI US 6992.35 USD —
-1.13
— — 6939.19 USD — 7028.81 USD — — — —
us US Tech Health Care IXHC US 1327.92 USD —
-0.97
— — 1320.94 USD — 1335.06 USD — — — —
us US Tech Composite Total Return XCMP US 32064.01 USD —
-0.21
— — 31953.83 USD — 32257.07 USD — — — —
us US Tech US 700 Small Cap Value I NQUS700SCV US 2681.12 USD —
-0.46
— — 2656.6 USD — 2682.84 USD — — — —
us US Tech Global Market Composite NQGM US 1980 USD —
-1.07
— — 1968.32 USD — 1989.07 USD — — — —
$2.67T
Total marketcap
$41.39B
Total volume
BTC 60.00%   •   ETH 10.58%
Dominance
Select currency